Johnson & Johnson Innovation - JJDC, Inc. - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Johnson & Johnson Innovation - JJDC, Inc. ownership history of PULMONX CORP
ValueSharesWeighting
Q2 2021$249,000
-3.5%
5,6390.0%0.02%
-24.2%
Q1 2021$258,000
-33.7%
5,6390.0%0.03%
-34.0%
Q4 2020$389,0005,6390.05%
Other shareholders
PULMONX CORP shareholders Q3 2023
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$43,898,0008.08%
ABG-WTT Global Life Science Capital Partners GP Ltd 93,831$4,140,0008.00%
Miura Global Management 570,000$25,148,0004.59%
Iron Triangle Partners LP 550,000$24,266,0002.50%
Beck Bode, LLC 116,442$5,137,0001.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,800,887$79,455,0001.41%
Affinity Asset Advisors, LLC 60,000$2,647,0000.95%
PURA VIDA INVESTMENTS, LLC 595,231$26,262,0000.82%
RTW INVESTMENTS, LP 1,129,600$49,838,0000.75%
ABG Innovation Capital Partners III GP Ltd 4,521$199,0000.67%
View complete list of PULMONX CORP shareholders